Schizophrenia Trial, Recruiting NCT03525054 Sponsor: University Hospital, Brest Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT03525054
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 15 to 30 years old (both minors and adults)
  • People who have reported suicidal thoughts, a suicidal act, or suicidal behaviour that has affected their emotional, social, or work life
  • People who are covered by a health insurance or social security scheme
  • People who are willing and able to sign a written consent form to participate
  • People taking antipsychotic medication that may affect thinking or memory may still be considered, but a one-week break from that medication would need to be scheduled before any assessments take place

Who may not be able to join:

  • People with a history of psychosis
  • People whose risk of harming themselves or others is considered too high to be safely managed outside of a hospital setting
  • People with an IQ below 70 (as measured by a specific cognitive test called the WAIS) (confirm with trial site)
  • People with a neurological condition or a serious physical health problem
  • People who are unable to take a one-week break from antipsychotic medication
  • People who do not wish to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02 98 01 52 06

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Brest
Registry
ClinicalTrials.gov
Start date
18 May 2018
Est. completion
2 May 2030

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Transition to schizophrenia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov